Francis Chou · Q1 2017
Chou Associates Management
Portfolio at the end of Q1 2017, from the 13F filed May 12, 2017. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Berkshire Hathaway BRK.A · history | 12.4% | Q2 2013 or earlier | No change |
| JPMorgan Chase JPM.WS · warrants · history | 9.6% | Q4 2014 | Reduce 44% |
| Resolute Forest Products RFP · history | 9.0% | Q2 2013 or earlier | No change |
| Bausch Health BHC · history | 8.6% | Q1 2016 | Add 20% |
| Citigroup C · history | 8.1% | Q2 2013 or earlier | No change |
| Wells Fargo WFC.WS · warrants · history | 7.3% | Q2 2013 or earlier | No change |
| Sanofi SNY · history | 6.2% | Q2 2013 or earlier | No change |
| Goldman Sachs GS · history | 5.7% | Q2 2013 or earlier | No change |
| Nokia NOK · history | 4.9% | Q2 2013 or earlier | Reduce 27% |
| Sears Holdings SHLD · history | 4.3% | Q2 2013 or earlier | No change |
| Endo ENDP · history | 3.5% | Q1 2017 | Buy |
| Beyond BYON · history | 3.3% | Q2 2013 or earlier | No change |
| MBIA MBI · history | 3.0% | Q2 2013 or earlier | No change |
| Teva TEVA · history | 2.3% | Q1 2017 | Buy |
| Bank of America BAC.WS.A · warrants · history | 2.0% | Q2 2013 or earlier | Reduce 36% |
| Sears Hometown and Outlet Stores SHOS · history | 1.7% | Q3 2014 | No change |
| Ascent Capital Group ASCMA · history | 1.4% | Q1 2015 | No change |
| BlackBerry BB · history | 1.4% | Q2 2013 or earlier | No change |
| SandRidge Energy SD · history | 1.0% | Q4 2016 | Add 225% |
| Atlanticus ATLC.CV · convertible notes · history | 0.9% | Q2 2016 | Reduce 26% |
| Chicago Bridge & Iron CBI · history | 0.7% | Q4 2014 | No change |
| Ascent Capital Group ASCMA.CV · convertible notes · history | 0.7% | Q3 2014 | No change |
| Ryanair RYAAY · history | 0.5% | Q2 2013 or earlier | No change |
| China Yuchai International CYD · history | 0.5% | Q2 2013 or earlier | No change |
| POSCO Holdings PKX · history | 0.4% | Q3 2015 | No change |
| Sears Canada SCC · history | 0.4% | Q4 2014 | No change |
| General Motors GM.WS · warrants · history | 0.1% | Q2 2016 | No change |
| 27 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q4 2016, adjusted for stock splits.
Sector weighting
| Financials & real estate | 49.2% | |
|---|---|---|
| Health care | 20.6% | |
| Consumer discretionary | 9.8% | |
| Materials | 9.4% | |
| Technology | 6.3% | |
| Industrials | 3.7% | |
| Energy | 1.0% |
What changed from Q4 2016
- Buy Endo ENDP 3.5% of the 13F
- Buy Teva TEVA 2.3% of the 13F
- Add 20% Bausch Health BHC 9.1% → 8.6%
- Add 225% SandRidge Energy SD 0.4% → 1.0%
- Reduce 44% JPMorgan Chase JPM.WS 15.9% → 9.6%
- Reduce 27% Nokia NOK 5.8% → 4.9%
- Reduce 36% Bank of America BAC.WS.A 2.7% → 2.0%
- Reduce 26% Atlanticus ATLC.CV 1.2% → 0.9%
- Sell SandRidge Energy SD.CV was 0.8%
- Sell AstraZeneca AZN was 0.2%
- Sell GSK GSK was 0.1%